Oncology News | pharmaphorum

News

Gilead moves closer to Chinese filing for Trodelvy in TNBC

Gilead Sciences' Trodelvy has met its objectives in a phase 2b trial in triple-negative breast cancer (TNBC) carried out in China by its partner Everest Medicines, moving it closer to a reg

News

West Chester - Circa November 2020: AstraZeneca plant. AstraZeneca has been working on a vaccine for the Coronavirus, COVID and COVID-19.

Scotland is world’s first country to greenlight Tagrisso for...

Scotland has given the green light to AstraZeneca’s Tagrisso for restricted use to treat adult patients with non-small cell lung cancer (NSCLC), making it the first country in the world to approve

News

Opdivo and chemotherapy combo increases survival in lung can...

Lung cancer drug Opdivo administered with chemotherapy has been shown to boost survival rates in patients with resectable non-small cell lung cancer (NSCLC).

News

Blackstone revs up Autolus' CAR with $250m fuel injection

Private equity firm Blackstone has agreed to provide up to $250 million in financing to UK biotech Autolus Therapeutics, to help it take acute lymphoblastic leukaemia (ALL) CAR-T therapy ob

News

Trial flop busts Deciphera's blockbuster hopes for Qinlock

Shares in Deciphera Pharma went into freefall on Friday after top-line results of a phase 3 trial of its Qinlock in rare cancer gastrointestinal stromal tumour (GIST) dashed its hopes of mo

News

EMA starts review of Enhertu for HER2+ gastric cancer

The EMA has started its review of AstraZeneca and Daiichi Sankyo's Enhertu for a second indication, as a second-line treatment for HER2-positive gastric cancer.

Gilead moves closer to Chinese filing for Trodelvy in TNBC

Scotland is world’s first country to greenlight Tagrisso for...

Opdivo and chemotherapy combo increases survival in lung can...

Blackstone revs up Autolus' CAR with $250m fuel injection

Trial flop busts Deciphera's blockbuster hopes for Qinlock

EMA starts review of Enhertu for HER2+ gastric cancer

J&J's oral IL-23 drug backed for psoriasis in EU

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks